Flt3 mutations from patients with acute myeloid leukemia induce transformation of 32D cells mediated by the Ras and STAT5 pathways

Blood

Volumn 96, Issue 12, 2000, Pages 3907-3914

  Mizuki, M ^a   Fenski, R ^a   Halfter, H ^a   Matsumura, I ^a   Schmidt, R ^a   Muller, C ^a   Gruning, W ^a   Kratz Albers, K ^a   Serve, S ^a   Steur, C ^a   Buchner, T ^a   Kienast, J ^a   Kanakura, Y ^a   Berdel, W E ^a   Serve, H ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STAT5 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; AUTOPHOSPHORYLATION; BONE MARROW CELL; CARCINOGENESIS; CELL TRANSFORMATION; CONTROLLED STUDY; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; ONCOGENE RAS; PRIORITY JOURNAL; PROGNOSIS; SIGNAL TRANSDUCTION;

EID: 0034554796     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.12.3907     Document Type: Article

References (43)

1. A receptor tyrosine kinase specific to hematopoietic stem and progenitor cell-enriched populations
2. Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family
3. STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells
4. Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs
5. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells
6. Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells
7. Biology and potential clinical applications of flt3 ligand
8. Flt3high and Flt3low CD34+ progenitor cells isolated from human bone marrow are functionally distinct
9. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors
10. Expression of the hematopoietic growth factor receptor FLT3 (STK- 1/Flk2) in human leukemias
11. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells
12. Effects of FLT3 ligand on human leukemia cells I. Proliferative response of myeloid leukemia cells
13. Effects of Flt3 ligand and interleukin-7 on in vitro growth of acute lymphoblastic leukemia cells
14. Effects of flt3 ligand on acute myeloid and lymphocytic leukemic blast cells from children
15. Effects of human FLT3 ligand on myeloid leukemia cell growth: Heterogeneity in response and synergy with other hematopoietic growth factors
16. Flt3 ligand stimulates proliferation and inhibits apoptosis of acute myeloid leukemia cells: Regulation of Bcl-2 and Bax
17. Leukemic predisposition of mice transplanted with gene-modified hematopoietic precursors expressing flt3 ligand
18. Internal tandem duplication of the flt3 gene found in acute myeloid leukemia
19. High expression but no internal tandem duplication of FLT3 in normal hematopoietic cells
20. Internal tandem duplication of the FLT3 gene is a novel modality of elongation mutation which causes constitutive activation of the product
21. Internal tandem duplication of the FLT3 gene and clinical evaluation in childhood acute myeloid leukemia: The Children's Cancer and Leukemia Study Group, Japan
22. Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia
23. Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia
24. Constitutive activation of Flt3 in AML and its consequences for growth of 32D cells
25. Human acute myeloid leukemia cells with internal tandem duplications in the Flt3 gene show reduced proliferative ability in stroma supported long-term cultures
26. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3
27. Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STAT5 homologs
28. The flt3 ligand promotes the survival of primitive hemopoietic progenitor cells with myeloid as well as B lymphoid potential: Suppression of apoptosis and counteraction by TNF-alpha and TGF-beta
29. Characterization of the protein encoded by the flt3 (flk2) receptor-like tyrosine kinase gene
30. Internal tandem duplication of the FLT3 gene is preferentially seen in acute myeloid leukemia and myelodysplastic syndrome among various hematological malignancies: A study on a large series of patients and cell lines
31. Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain
32. Neoplastic transformation of normal hematopoietic cells by constitutively activating mutations of c-kit receptor tyrosine kinase
33. Activating mutation in the catalytic domain of c-kit elicits hematopoietic transformation by receptor self-association not at the ligand-induced dimerization site
34. Inhibition of spontaneous receptor phosphorylation by residues in a putative alphahelix in the kit intracellular juxtamembrane region
35. c-KIT expression enhances the leukemogenic potential of 32D cells
36. Phosphatidylinositol-3' kinase is not required for mitogenesis or internalization of the Flt3/Flk2 receptor tyrosine kinase
37. p85 subunit of P13 kinase does not bind to human Flt3 receptor, but associates with SHP2, SHIP, and a tyrosine-phosphorylated 100-kDa protein in Flt3 ligand-stimulated hematopoietic cells
38. Flt3 signaling involves tyrosyl-phosphorylation of SHP-2 and SHIP and their association with Grb2 and Shc in Baf3/Flt3 cells
39. Essential role of ras and Pl3K pathways in Flt3 dependent proliferation and survival
40. Retroviral mediated gene transfer of Flt3 ligand enhances proliferation and MAP kinase activity of AML5 cells
41. Tandemduplicated Flt3 constitutively activates STAT5 and MAP kinase and introduces autonomous cell growth in IL-3-dependent cell lines
42. Transcriptional regulation of the beta-casein gene by cytokines: Cross-talk between STAT5 and other signaling molecules
43. Interleukin-6-induced STAT3 transactivation and ser727 phosphorylation involves vav, rac-1 and the kinase SEK-1/MKK-4 as signal transduction components